Prof. Rubin Zhang

Department of Medicine

Tulane University School of Medicine, USA

Email: [email protected]

Qualifications

1985-1989 Ph.D., San Yat-Sen University of Medical Sciences, China

1980-1985 M.Sc., Nantong Medical School, China

Publications (Selected)

1. Carsky, K.P., Ferrin, P.C., McDermott, C.E., Chernobylsky, D., Buell, J. and others. Recurrent Antibody-Mediated Rejection: A Nihilistic Approach. Journal of the American College of Surgeons, 227(4), e225, 2018.
2. Monlezun, D.J., John, M., Dortonne, I., Carsky, K.P., Chernobylsky, D., Ferrin, P. and others. Postrenal transplant infection: What is the effect of specific immunosuppressant agents? Surgery, 164(4):895-899, 2018.
3. McDermott, C., Carsky, K., Ferrin, P., Gaines, A., Chernobylsky, D., Killackey, M. and others. Analysis of Cost Effectiveness of Treatment for Acute Antibody-Mediated Rejection. American Journal of Transplantation, 18, 734, 2018.
4. Chernobylsky, D., Carsky, K., McDermott, C., Ferrin, P., Fernandez, R., Gaines, I. and others. Impact of Psychosocial Variables on Renal Allograft Rejection Risk: A Multivariate Analysis. American Journal of Transplantation, 18, 695, 2018.
5. Allen, Z., Beatrice, Z., Yaozhong, L., Mary, K., Anil, P., Joseph, B., Brent, A., Fred, T. and others. Long-Term Outcomes of Induction Therapies with Alemtuzumab, Basiliximab or Methylprednisolone in Kidney Transplant Patients with Delayed Graft Function. Journal of Transplant Surgery, 1(1), 2018.
6. Zhang, R. Donor-specific antibodies in kidney transplant recipients. Clinical Journal of the American Society of Nephrology, 13(1):182-192, 2018.
7. Umber, A., Killackey, M., Paramesh, A., Alper, B., Teran, F., Baudy, A., Liu, Y. and others. Three Induction Therapies on Patients with Delayed Graft Function After Kidney Transplantation, a Three-Year Outcome Analysis. American Journal of Transplantation, 17, 627, 2017.
8. Umber, A., Killackey, M., Paramesh, A., Liu, Y., Qin, H., Atiq, M., Lee, B., Alper, A.B. and others. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation. Journal of Nephrology, 30(2):289-295, 2017.
9. Gadde, S., Lee, B., Kidd, L. and Zhang, R. Antineutrophil cytoplasmic antibodies crescentic allograft glomerulonephritis after sofosbuvir therapy. World Journal of Nephrology, 5(6):547, 2016.
10. John, M., Dortonne, I., Kim, B., Li, C., Killackey, M., Paramesh, A., Lee, B. and others. Do Powerful Induction Antibodies Increase Post Renal Transplant Infections? American Journal of Transplantation, 16, 784-785, 2016.
11. Hauch, A., John, M., Smith, A., Dortonne, I., Patel, U., Kandil, E., Killackey, M. and others. Generics: Are all immunosuppression agents created equally? Surgery, 158(4):1049-1055, 2015.
12. Smith, A., John, M., Dortonne, I., Paramesh, A., Killackey, M., Zhang, R., Lee, B. and others. Infections After Alemtuzumab Induction: A Non Issue? American Journal of Transplantation, 15, 2015.
13. John, M., Smith, A., Dortonne, I., Paramesh, A., Killackey, M., Lee, B., Zhang, R. and others. Risks for Readmission Post-Renal Transplant: A Co-Morbid Condition. American Journal of Transplantation, 15, 2015.
14. John, M., Smith, A., Dortonne, I., Paramesh, A., Killackey, M., Lee, B., Zhang, R. and others. Effect of Antibody Mediated Rejection on Long-Term Renal Allograft Function. American Journal of Transplantation, 15, 2015.
15. Atiq, M., Umber, A., Alper, B., Lee, B., Simon, E. and Zhang, R. A COMPARISON OF THREE INDUCTION THERAPIES ON PATIENTS WITH DELAYED GRAFT FUNCTION AFTER KIDNEY TRANSPLANT. American Journal of Kidney Diseases, 65(4), A20, 2015.
16. Smith, A., Couvillion, R., Zhang, R., Killackey, M., Buell, J., Lee, B., Saggi, B.H. and others. Incidence and management of leukopenia/neutropenia in 233 kidney transplant patients following single dose alemtuzumab induction. Transplantation Proceedings, 46(10):3400-3404, 2014.
17. Khan, E., Killackey, M., Kumbala, D., LaGuardia, H., Liu, Y.J., Qin, H.Z., Alper, B. and others. Long-term outcome of ketoconazole and tacrolimus co-administration in kidney transplant patients. World Journal of Nephrology, 3(3):107, 2014.
18. Hauch, A., Killackey, M., Paramesh, A., Saggi, B., Macaluso, J., Alpert, A., Lee, B. and others. Generics: Are All Immunosuppression Agents Created Equally? Transplantation, 98, 551, 2014.
19. Umber, A., Atiq, M., Liu, Y., Killackey, M., Paramesh, A., Alper, B., Lee, B., Saggi, B. and others. A Comparison of Three Induction Therapies On Patients With Delayed Graft Function After Kidney Transplantation.: Abstract# C1802. Transplantation, 98, 581, 2014.
20. Hauch, A., Killackey, M., Paramesh, A., Saggi, B., Macaluso, J., Alpert, A., Lee, B. and others. Generics: Are All Immunosuppression Agents Created Equally?: Abstract# B1003. Transplantation, 98, 551, 2014.

Personal Details

https://schoolofgradstudies.lsuhs.edu/academics/pharmacology-toxicology-and-neuroscience/research/zhao-lab

https://www.researchgate.net/profile/Yunfeng-Zhao-2

WoS Researcher ID: CKR-7364-2022